Fighting OxyContin Counterfeiting and Diversion with RFID and GS1 Labeling Softwareby sterling1 on Nov 27, 2008 • 3:13 pm No Comments
In an email forwarded to me recently, I became aware of a new two-page case study about Purdue Pharma expanding and enhancing their serialization & EPC/RFID programs using the GS1 EPCglobal Gen2 Standard. You can access the complete story via this link to GS1 Healthcare US. Just scroll down the home page, and on the left sidebar the link is the second one under ‘What’s New.’
To give you a good idea of what you’ll find there and what this is all about, here’s a short excerpt about what was accomplished in a year:
In June 2006, Purdue Pharma initiated an ambitious program to upgrade and expand their Electronic Product Code™/Radio Frequency Identification (EPC/RFID) and serialization programs using GS1® standards. This effort established RFID serialization for bottles containing OxyContin® Tablets by collecting item to case to pallet data relationships to support item level track and trace through the supply chain. This program had four objectives:
- GS1 Compliance, GS1 Labeling and GS1 Traceability Standards Forge Ahead
- GS1 Barcode Country Designation Not a Certain Identifier of COO…? Oh Oh!
- Tainted Products: "It's going to get worse before it gets better…"
- FDA Public Meetings on Produce Traceability Set for Oct. 16
- Worldwide Supply Chain Management Software Revenue Grows 18 Percent in 2007